Europe
The clinical study on ANG-3777 demonstrated a modest but not clinically significant difference in the placebo group’s estimated glomerular filtration rate.
BioNTech plans to increase its manufacturing capacity in Africa over time through the supplementation of new manufacturing lines and construction of additional manufacturing sites.
Nuravax is developing an Alzheimer’s vaccine to induce therapeutically potent concentrations of antibodies against pathological proteins. Know more here.
Janssen reported analyses in which STELARA is showing promising results as a first-line therapy for Crohn’s Disease (CD) and Ulcerative Colitis (UC).
It was yet another busy week for clinical trial news. Here’s a look.
The designation is based on data from two Phase I trials, which showed the drug to be safe, demonstrating early efficacy.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
The license and collaboration agreement allows Janssen to use F-star’s proprietary technology in the research, development and commercialization of novel bispecific antibodies.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.
The CDC has warned that COVID-19 during pregnancy can result in preterm birth and other negative outcomes, including stillbirths.
PRESS RELEASES